Biomarin Pharmaceutical Incis A Global Biotechnology Company Based In San Rafaelcaliforniafounded In March 1997It Specializes In Developing And Commercializing Therapies For Raregenetic Diseaseswith A Workforceof 401 Employees And Reported Revenueof $2 419 Billion In 202 Biomarin Has Established A Strong Presencein Therarediseasetherapeutics Market Thecompany Focuses On Enzymereplacement Therapies And Genetic Medicineinnovationtargeting Conditions With Significant Unmet Medical Needsits Key Products Includealdurazymeafor Mucopolysaccharidosis Typeinaglazymeafor Mps Vipalynziqafor Phenylketonuriaand Roctavianafor Severehemophilia Aamong Othersbiomarin Also Maintains A Robust Pipelineaimed At Conditions Likeduchennemuscular Dystrophy And Emphasizes Genetherapy And Precision Medicinein Its Research And Development Effortswith Manufacturing Facilities In California And Irelandbiomarin Ensures A Resilient Global Supply Chain To Support Its Operations
India
